VAERS reports by lot

Moderna COVID-19 lot 025520-2A: VAERS reports

39 VAERS reports list lot 025520-2A as a Moderna COVID-19 vaccine, received between 2020-12-30 and 2022-02-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
39
Reports
10%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3623%
General / Systemic (non-local)2617%
Neurological2315%
Musculoskeletal1912%
Cardiac / Cardiovascular128%
Dermatological (non-injection-site)117%
Allergic / Anaphylactic96%
Gastrointestinal85%
Autoimmune / Immune-mediated53%
Thrombotic / Hematological32%
Respiratory32%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 11).

California15
Colorado5
Oregon5
Missouri3
Iowa2
Oklahoma1
Arizona1
Michigan1
Louisiana1
New Mexico1
Kansas1

Reports by month received

2020-122
2021-0117
2021-022
2021-035
2021-073
2021-086
2021-111
2021-121
2022-011
2022-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.